SHORT REPORT
Depression, anxiety and panic disorders in chronic obstructive pulmonary disease patients: correlations with tobacco use, disease severity and quality of life
 
More details
Hide details
1
“Grigore T. Popa” University of Medicine and Pharmacy Iasi, Iasi, Romania
2
“Iuliu Hatieganu” University of Medicine and Pharmacy Cluj-Napoca, Cluj-Napoca, Romania
3
“Gheorghe Asachi” Technical University Iasi, Iași, Romania
CORRESPONDING AUTHOR
Antigona Carmen Trofor   

“Grigore T. Popa” University of Medicine and Pharmacy Iasi, No 16 Universitatii Street, 700115 Iasi, Romania
Publish date: 2017-04-07
 
Tob. Induc. Dis. 2017;15(April):23
KEYWORDS
ABSTRACT
Background:
The objective of this study is to assess anxiety, depression and panic disorders among patients diagnosed with COPD and to investigate their correlation with disease severity, quality of life as well as tobacco use.

Methods:
An observational study was performed between January and September 2014 among 60 patients diagnosed with COPD. COPD staging according to GOLD criteria, while anxiety and depression were assessed using Hospital Anxiety and Depression Scale and panic attacks were evaluated based on ICD 10 criteria.

Results:
Almost 40% of the sample were smokers, the medium packs-years was 34.3 and the medium Fagerstrom score was 7.5. Overall, mean Modified Medical Research Council Dyspnea Scale (mMRC) was 2.86, mean COPD Assessment Test (CAT) score was 21.75 and study participants had 1.93 COPD exacerbations/year. Mean distribution of anxiety and depression symptoms scores among COPD subjects was 10.65 ± 3.5 and 9.93 ± 3.8, respectively. Smokers and ex-smokers had similar scores with regard to anxiety, depression or the presence of panic attacks. The results of the bivariate correlations indicated associations between anxiety, depression, panic attacks and disease severity, as well as poor quality of life of patients with COPD, regardless of their current tobacco use status.

Conclusions:
In conclusion, the results of this study indicate that anxiety, depression and panic attacks were constant characteristics among COPD patients- regardless of their current tobacco use.

 
REFERENCES (33)
1.
Chang CK, Broadbent M, Fernandes AC, Lee W, Hotopf M, Stewart R. All-cause mortality among people with serious mental illness (SMI), substance use disorders, and depressive disorders in southeast London: a cohort study. BMC Psychiatry. 2011;10:77.
 
2.
Wagena EJ, Arrindell WA, Wouters EF, van Schayck CP. Are patients with COPD psychologically distressed? Eur Respir J. 2005;26:242–8.
 
3.
Tetikkurt C, Ozdemir I, Tetikkurt S, Yılmaz N, Ertan N, Bayar N. Anxiety, depression in COPD patients and correlation with sputum and BAL cytology. Multidiscip Respir Med. 2011;6:226–31.
 
4.
Dahlén I, Janson C. Anxiety and depression are related to the outcome of emergency treatment in patients with obstructive pulmonary disease. Chest. 2002;122:1633–7.
 
5.
Maurer J, Rebbapragada V, Borson S, et al. Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest. 2008;134(4 Suppl):43S–56.
 
6.
Naylor C, Parsonage M, McDaid D, Knapp M, Fossey M, Galea A. Long-term conditions and mental health The cost of co-morbidities. The King’s Fund and Centre for Mental Health. 2012.
 
7.
Gratziou C, Florou A, Ischaki E, et al. Smoking cessation effectiveness in smokers with COPD and asthma under real life conditions. Respir Med. 2014;108(4):577–83.
 
8.
John U, Meyer C, Rumpf HJ, Hapke U. Smoking, nicotine dependence and psychiatric comorbidity-a population-based study including smoking cessation after three years. Drug Alcohol Depend. 2004;76(3):287–95.
 
9.
Covey LS, Bomback A, Yan GW. History of depression and smoking cessation: a rejoinder. Nicotine Tob Res. 2006;8(2):315–9.
 
10.
Smith SS, Jorenby DE, Leischow SJ, et al. Targeting smokers at increased risk for relapse: treating women and those with a history of depression. Nicotine Tob Res. 2003;5(1):99–109.
 
11.
Yohannes AM, Baldwin RC, Connolly MJ. Prevalence of depression and anxiety symptoms in elderly patients admitted in post-acute intermediate care. Int J Geriatr Psychiatry. 2008;23(11):1141–7.
 
12.
Kupiainen H, Kinnula VL, Lindqvist A, et al. Successful Smoking Cessation in COPD: Association with Comorbidities and Mortality. Pulm Med. 2012;2012:725024.
 
13.
McSweeny AJ, Grant I, Heaton RK, et al. Life quality of patients with chronic obstructive pulmonary disease. Arch Intern Med. 1982;142:473–8.
 
14.
Prigatano GP, Wright EC, Levin D. Quality of life and its predictors in patients with mild hypoxemia and chronic obstructive pulmonary disease. Arch Intern Med. 1984;144:1613–9.
 
15.
Yohannes AM, Baldwin RC, Connolly MJ. Depression and anxiety in elderly outpatients with chronic obstructive pulmonary disease: prevalence, and validation of the BASDEC screening questionnaire. Int J Geriatr Psychiatry. 2000;15:1090–6.
 
16.
Glaxo Smith Kline. 2009. http://www.catestonline.org/en...).
 
17.
Celli BR, Cote CG, Lareau SC, Meek PM. Predictors of Survival in COPD: more than just the FEV1. Respir Med. 2008;102 Suppl 1:S27–35. Cough and Sputum Assessment Questionnaire.
 
18.
Crawford B, Monz B, Hohifeld J, Roche N, Rubin B, Magnussen H, Niven C, Ghafouri M, McDonald J, Tetziaff K. Development and validation of a cough and sputum assessment questionnaire. Respir Med. 2008;102(11):1545–55. doi:10.1016/jrmed.2008.06.009.Epub.
 
19.
Magureanu IL, Furtunescu F. Importanta determinarii prevalentei BPOC. Pneumologia. 2013;62:239–46.
 
20.
Global Innitiative for Chronic Obstructive Lung Diseases (GOLD). Global Strategy for the Diagnoses, Management and Prevention of Chronic Obstructive Pulmonary Diseases. http://www.msc.es/organizacion....
 
21.
Trofor A, Mihaltan F, Todea D, Mihaicuta S, et al. Ghidul Societatii Romane de Pneumologie: Ghid de renuntare la fumat si asistenta de specialitate a fumatorului (GREFA). Iasi: Tehnopress; 2010.
 
22.
Zigmond A. Snaith.Cum să te laşi de fumat. Recomandări, metode, tratamente. Bucureşti: Ed. Tei; 2003.
 
23.
Maurer J, Rebbapragada V, Borson S, Goldstein R, Kunik ME, Yohannes AM, et al. Anxiety and Depression in COPD: Current Understanding, Unanswered Questions, and Research Needs. Chest. 2008;134:43–56.
 
24.
Lacasse Y, Rousseau L, Maltais F. Prevalence of depressive symptoms and depression in patients with severe oxygen dependent chronic obstructive pulmonary disease. J Cardiopulm Rehabil. 2001;21:80–6.
 
25.
Kunik ME, Roundy K, Veazey C. Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest. 2005;127:1205–11.
 
26.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Washington DC: American Psychiatric Association; 1994. p. 430–41.
 
27.
Smoller J, Pollack M, Otto M. Panic anxiety, dyspnea, and respiratory disease. Am J Respir Crit Care Med. 1996;154:6–7.
 
28.
Salerno FG, Carone M. Anxiety and depression in COPD. Multidiscip Respir Med. 2011;6:212–3.
 
29.
Ng TP, Niti M, Tan WC, Cao Z, Ong KC, Eng P. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital admission, symptom burden, functional status and quality of life. Arch Intern Med. 2007;167:60–7.
 
30.
Naylor C, Parsonage M, McDaid D, Knapp M, Fossey M, Galea A. Long-term conditions and mental health. The cost of co-morbidities. The Kings Fund and Centre for Mental Health. 2012. https://www.kingsfund.org.uk/s....
 
31.
Baraniak A, Sheffield D. The efficacy of psychologically based interventions to improve anxiety, depression and quality of life in COPD: a systematic review and meta-analysis. Patient Educ Couns. 2011;83:29–36.
 
32.
National Institute of Clinical Excellence. Depression in adults with a chronic physical health problem. Treatment and management. National Collaborating Centre for Mental Health. 2009. https://www.nice.org.uk/guidan....
 
33.
Generalised anxiety disorder and panic disorder in adults: management Clinical guideline Published: 26 January 2011 nice.org.uk/guidance/cg113.
 
 
CITATIONS (6):
1.
Tobacco Treatment Guideline for High Risk Groups: A pilot study in patients with Chronic Obstructive Pulmonary Disease
Antigona Trofor, Sophia Papadakis, Lucia Lotrean, Ioana Buculei- Porosnicu, Vergina Vyzikidou, Vaso Evangelopoulou, Constantine Vardavas, Panagiotis Behrakis
Tobacco Induced Diseases
 
2.
Influence de l’anxiété et de la dépression sur les exacerbations au cours de la BPCO
M. Underner, A. Cuvelier, G. Peiffer, J. Perriot, N. Jaafari
Revue des Maladies Respiratoires
 
3.
BPI-ANCA in chronic obstructive pulmonary disease with pulmonary Pseudomonas aeruginosa colonisation: a novel indicator of poor prognosis
Y Tian, T Zeng, L Tan, Y Wu, J Yu, J Huang, Z Pei
British Journal of Biomedical Science
 
4.
Impact of the Tobacco Treatment Guidelines for High Risk Groups (TOB.g): A pilot study among physicians specializing in CVD, Diabetes and COPD
Antigona Trofor, Sophia Papadakis, Constantine Vardavas, Lucia Maria Lotrean, Christina-Maria Gavrilescu, Vasso Evangelopoulou, Theodosia Peleki, Letitia Trofor (PhD student), Panagiotis Κ. Behrakis
Tobacco Prevention & Cessation
 
5.
Anxiety and depression in patients with chronic obstructive pulmonary disease and their relation to serum vitamin D levels
Derya KOCAKAYA, YILDIZELI OLGUN, Ozan KOCAKAYA, Huseyin ARIKAN, Emel ERYUKSEL, Emel ERYUKSEL
Marmara Medical Journal
 
6.
Patterns of tobacco use, quit attempts, readiness to quit and selfefficacy among smokers with anxiety or depression: Findings among six countries of the EUREST-PLUS ITC Europe Surveys
Ioanna Petroulia, Christina Kyriakos, Sophia Papadakis, Chara Tzavara, Filippos Filippidis, Charis Girvalaki, Theodosia Peleki, Paraskevi Katsaounou, Ann McNeill, Ute Mons, Esteve Fernández, Tibor Demjén, Antigona Trofor, Aleksandra Herbeć, Witold Zatoński, Yannis Tountas, Geoffrey Fong, Constantine Vardavas, on consortium*
Tobacco Induced Diseases
 
eISSN:1617-9625